DNA vaccine protection against SARS-CoV-2 in rhesus macaques

2020 Science 1,118 citations

Abstract

Prototype DNA vaccines for SARS-CoV-2 The development of a vaccine to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an urgent biomedical need. Yu et al. designed a series of prototype DNA vaccines against the SARS-CoV-2 spike protein, which is used by the virus to bind and invade human cells. Analysis of the vaccine candidates in rhesus macaques showed that animals developed protective humoral and cellular immune responses when challenged with the virus. Neutralizing antibody titers were also observed at levels similar to those seen in humans who have recovered from SARS-CoV-2 infection. Science , this issue p. 806

Keywords

VirologyDNA vaccinationImmune systemAntibodyBiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusTiterNeutralizing antibodyCoronavirusImmunologyCoronavirus disease 2019 (COVID-19)Antibody titerMedicineImmunizationInfectious disease (medical specialty)Disease

Affiliated Institutions

Related Publications

SARS-CoV-2 vaccines in development

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in late 2019 in China and is the causative agent of the coronavirus disease 2019 (COVID-19) pande...

2020 Nature 2193 citations

Publication Info

Year
2020
Type
article
Volume
369
Issue
6505
Pages
806-811
Citations
1118
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1118
OpenAlex

Cite This

Jingyou Yu, Lisa H. Tostanoski, Lauren Peter et al. (2020). DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science , 369 (6505) , 806-811. https://doi.org/10.1126/science.abc6284

Identifiers

DOI
10.1126/science.abc6284